Clinical Trial Update: Assessment of Safety ,Tolerance and Pharmacokinetics Clinical Efficacy With BAT1308 in Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating BAT1308 in advanced solid tumors for safety, tolerability, pharmacokinetics, and preliminary efficacy; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• BAT1308 (BAT1308)

Snippet

Sponsor: Bio-Thera Solutions | Conditions: Advanced Solid Tumor | Phase 1 | Status: COMPLETED